MétaCan
Menu
Back to cohort

An international study of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different cancer sites.

2012· article· en· W2608082715 on OpenAlexaff
Chantal Quinten, Efstathios Zikos, Miriam Sprangers, Eva Greimel, Francesca Martinelli, Bryce B. Reeve, Jolie Ringash, Carolyn Gotay, John Maringwa, Corneel Coens, Divine Ediebah, Madeleine King, David Osoba, Charles S. Cleeland, Hans‐Henning Flechtner, Jospeh Schmucker-Von Koch, Martin Taphoorn, Joachim Weis, Kristin Bjordal, Andrew Bottomley

Bibliographic record

VenueJournal of Clinical Oncology · 2012
Typearticle
Languageen
FieldMedicine
TopicMultiple and Secondary Primary Cancers
Canadian institutionsUniversity of British ColumbiaPrincess Margaret Cancer CentreUniversity of Toronto
Fundersnot available
KeywordsMedicineInternal medicineCancerLung cancerOncologyHazard ratioColorectal cancerProportional hazards modelQuality of life (healthcare)NauseaBreast cancerConfidence interval

Abstract

fetched live from OpenAlex

6002 Background: The prognostic value for survival of HRQOL data derived from self-report questionnaires, has been well documented in cancer research. The objective of this study was to examine the prognostic value of HRQOL parameters for different cancer sites using one standardized and validated patient self-assessment tool. Methods: A total of 11 different cancer sites, pooled from 30 European Organisation for Research and Treatment of Cancer (EORTC) Randomized Controlled Trials (RCTs), were selected for this study. For each cancer site, univariate and multivariate Cox proportional hazard modeling was used to assess the prognostic value (p<0.05) of 15 HRQOL parameters, assessed with the EORTC QLQ-C30 at baseline before randomization, for overall survival. Models were adjusted for the parameters age, gender, distant metastasis, World Health Organization performance status and stratified by clinical study. Results: A total of 7,417 patients completed the EORTC QLQ-C30 before randomization. For brain cancer cognitive functioning (CF) (hazard ratio (HR) =0.95; p<.0001) was prognostic. For breast cancer nausea and vomiting (NV) (HR=1.17; p=0.0011) was a prognostic indicator. For colorectal cancer physical functioning (PF) (HR=0.93; p<.0001), NV (HR=1.07; p<.0001), and appetite loss (AP) (HR=1.07; p<.0001) predicted survival. For esophageal cancer PF (HR=0.88; p=0.0072) and for head and neck cancer NV (HR=1.14; p=0.0097) were prognostic. For lung cancer PF (HR=0.94; p=0.0006) and pain (HR=1.08; p<0.0001), for melanoma dyspnea (HR=1.06; p<.0001), for ovarian cancer NV (HR=1.2; p<.0001), for pancreatic cancer global QOL (HR=0.83; p=0.0073), for prostate cancer role functioning (RF) (HR=0.96; p=0.006) and AP (HR=1.07; p<.0001), and for testis cancer RF (HR=0.81; p=0.0144) were predictors of survival. Conclusions: Our findings show that different HRQOL parameters provide prognostic information for survival for patients with different tumor sites and that no single HRQOL scale can predict survival in all cancer patients. Thus, each cancer site needs careful examination and no single QOL paramenter can predict survival in all cancer diseases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.242
metaresearch head score (Gemma)0.291
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.242
Threshold uncertainty score0.935

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2420.291
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.007
Bibliometrics0.0030.008
Science and technology studies0.0010.002
Scholarly communication0.0040.003
Open science0.0010.003
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.506
GPT teacher head0.579
Teacher spread0.072 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicMultiple and Secondary Primary CancersFrench-language works237,207